Late-stage cancer patients given LSD micro doses

University of Auckland researchers have recruited 40 people for the trial - who will receive either a low dose of the psychedelic hallucinogen or placebos - alongside pyschotherapy, Dr Lisa Reynolds from the School of Psychological Medicine at University of Auckland speaks to Susana Lei'ataua.